Summary
- Current Price
- As of today, ACRV price is $1.67, up +9.15% on
- Current Price All-Time High
- ACRV price is currently -93.44% below its historical high of $25.47 set on
- Market Cap
- ACRV current market cap is $53M, down -67.17% year-over-year
- PE Ratio
- ACRV PE ratio is unknown
- Revenue
- ACRV current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- As of today, the next earnings release for ACRV has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Acrivon Therapeutics, Inc. |
| Ticker | NASDAQ: ACRV |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | acrivon.com |
| Employees | 75 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $1.67 | ||
| Price, 1D Change | +9.15% | |
| $53M | ||
| - | ||
| - | ||
| 1.68 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$2.38 | ||
| EPS, 1Y Change | +12.84% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$2.38 | ||
| EPS Estimate | N/A | -$1.96 |
| EPS Est. Change | N/A | +17.62% |
| $0.00 | ||
| Revenue Estimate | N/A | $129.33K |
| Revenue Est. Change | N/A | - |
| $1.67 | ||
| Price Target | - | $10.50 |
| Price Tgt. Change | - | +528.74% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.62 | -$2.74 | -4.40% | |
| -$2.60 | -$2.38 | +8.38% | |
| -$1.96 | N/A | +17.62% | |
| -$1.84 | N/A | +22.92% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| $129.33K | N/A | - | |
| $1.17M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -67.51% | ||
| -92.05% | ||
| -67.17% | ||
| -88.55% | ||
| 0.00% | ||
| 0.00% | ||
| +12.84% | ||
| -206.14% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $1.67 | ||
| $1.71 | ||
| SMA 200 vs Price | +2.17% | |
| $1.92 | ||
| SMA 50 vs Price | +15.04% | |
| 1.68 | ||
| $0.16 | ||
| 48.66 | ||
| 134.94% | ||
| 120.36% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$2.38 | ||
| -$1.01M | ||
| - | ||
| -$89.20M | ||
| - | ||
| -$80.56M | ||
| - | ||
| -$88.19M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.02 | ||
| 10.55 | ||
| 10.55 | ||
| - | ||
| - | ||
| -0.30 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 0.41 | ||
| 0.84 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $176.79M | ||
| $39.82M | ||
| $196.59M | ||
| $181.63M | ||
| $19.80M | ||
| $17.21M | ||
| $3.65M | ||
| $1.06M | ||
| $758.00K |
Expenses
| Metric | Date | Value |
|---|---|---|
| $89.20M | ||
| $89.20M | ||
| $1.01M | ||
| $25.21M | ||
| $1.01M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$65.67M | ||
| -$51.77M | ||
| $121.03M | ||
| $2.77M | ||
| -$68.44M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Piper Sandler | → | |
| HC Wainwright & Co. | → | |
| Oppenheimer | → | |
| Jones Trading | → | |
| Oppenheimer | → | |
| Oppenheimer | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Citizens Capital Markets | → | |
| Cantor Fitzgerald | → |
Analyst sentiment
Institutional ownership
Screeners with ACRV
FAQ
What is the ticker symbol for Acrivon Therapeutics, Inc.?
The ticker symbol for Acrivon Therapeutics, Inc. is NASDAQ:ACRV
Does Acrivon Therapeutics, Inc. pay dividends?
No, Acrivon Therapeutics, Inc. does not pay dividends
What sector is Acrivon Therapeutics, Inc. in?
Acrivon Therapeutics, Inc. is in the Healthcare sector
What industry is Acrivon Therapeutics, Inc. in?
Acrivon Therapeutics, Inc. is in the Biotechnology industry
What country is Acrivon Therapeutics, Inc. based in?
Acrivon Therapeutics, Inc. is headquartered in United States
When did Acrivon Therapeutics, Inc. go public?
Acrivon Therapeutics, Inc. initial public offering (IPO) was on November 15, 2022
Is Acrivon Therapeutics, Inc. in the S&P 500?
No, Acrivon Therapeutics, Inc. is not included in the S&P 500 index
Is Acrivon Therapeutics, Inc. in the NASDAQ 100?
No, Acrivon Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Acrivon Therapeutics, Inc. in the Dow Jones?
No, Acrivon Therapeutics, Inc. is not included in the Dow Jones index
When was Acrivon Therapeutics, Inc. last earnings report?
Acrivon Therapeutics, Inc.'s most recent earnings report was on August 14, 2025
When does Acrivon Therapeutics, Inc. report earnings?
The date for Acrivon Therapeutics, Inc.'s next earnings report has not been announced yet
Data Sources & References
- ACRV Official Website acrivon.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1781174/000095017025046056/0000950170-25-046056-index.htm
- ACRV Profile on Yahoo Finance finance.yahoo.com/quote/ACRV
- ACRV Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/acrv